FDA Approved: NELARABINE — Original Application (Dr. Reddy's Laboratories, Inc.)

View source ↗

Summary

FDA approves Dr. Reddy's Nelarabine as a generic under an Original Application for use in treating T-cell acute lymphoblastic leukemia and T-cell lymphoblastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)